Suggestions
Hanan Balkhy
Assistant Director-General for Antimicrobial Resistance at the World Health Organization
Dr. Hanan Balkhy is a prominent Saudi physician and public health expert who has held several key positions in global health. She was appointed as the World Health Organization's (WHO) Regional Director for the Eastern Mediterranean in January 2024, taking office on February 1, 2024.13 Prior to this role, Dr. Balkhy served as the first Assistant Director-General for Antimicrobial Resistance (AMR) at WHO headquarters since 2019.24
Dr. Balkhy's career highlights include:
- Executive Director for Infection Prevention and Control at the Ministry of National Guard, Saudi Arabia.34
- Director of the Gulf Cooperation Council Centre for Infection Control.3
- Leader of the WHO Collaborating Centre for Infection Prevention and Control and Antimicrobial Resistance in Saudi Arabia.13
- Professor of Pediatric Infectious Diseases with over two decades of experience.2
- Chair of the Infectious Disease Research Unit at King Abdullah International Medical Research Center.2
Dr. Balkhy received her medical degree from King Abdulaziz University in Saudi Arabia, completed her pediatric residency at Massachusetts General Hospital, and a pediatric infectious diseases fellowship at Cleveland Clinic Foundation and Case Western Reserve University in the United States.12
Throughout her career, Dr. Balkhy has been involved in various WHO committees and has published extensively in peer-reviewed journals.24 Her expertise in infectious diseases, antimicrobial resistance, and public health has made her a leading figure in global health initiatives.
Highlights
The World Health Organization Global Research Agenda for #AMR in Human Health: Priorities for research to fill critical gaps on AMR by 2030 on prevention, diagnosis, and treatment and care of bacterial and fungal pathogens, and resistant tuberculosis, will be launched on 22 June 2023 12:00- 13:30 CEST. The research agenda aims to catalyze research on the #epidemiology, burden and drivers of AMR, strategies to prevent resistance emergence and transmission, the discovery and development of new #diagnostics and better #treatments regimens, and how to optimize the use of current tools and implement them more efficiently. Ultimately, it aims to inform evidence-based policies and interventions to strengthen the AMR response, especially in low-and-middle-income countries (LMICs). The research agenda was developed following a rigorous and transparent process starting with a scoping review of over 3,000 documents including over 2,300 knowledge gaps. Following several rounds of review and consolidation, over 230 experts globally across a range of AMR-related disciplines scored the questions against five criteria in a transparent, independent and reproducible approach. This enabled the identification of global AMR research priorities for human health by 2030. To learn about the 30 AMR research priorities we want the world to focus on, register here. https://lnkd.in/edhft4-W.
Closing date: Tuesday 25 October 2022 9:00 AM CEST
World Health Organization is calling for expert contributions to the development of the Global Antimicrobial Resistance (AMR) Research Agenda in human health.
The target audience for this consultation is researchers, program managers and implementers, or policy-makers with expertise in AMR globally.
WHO calls for contributions from AMR experts globally to:
Review the list of research questions identified through the scoping review and propose individual research questions for removal, if they meet the provided exclusion criteria.Propose one research question for addition if there are important gaps and in line with the provided inclusion criteria.
The input received through this exercise will contribute to preparing a final list of research questions for prioritization.
